Back to Our Investment Approach

Healthcare

General Atlantic has been a leading healthcare investor over the past 25 years, starting in healthcare IT and expanding into technology-enabled services, providers of care, care management & coordination, population risk management and proven medical technologies. We pursue highly thematic investments that aim to improve the quality of care and/or reduce the cost of care. We partner with strong, experienced and knowledgeable entrepreneurs and management teams to help scale proven business models into industry leading companies.

Our Current and Former Healthcare Portfolio VIEW ALL

Conexa ×

Conexa is a leading telemedicine provider in Brazil.

  • Region: Latin America
  • Sector: Healthcare
  • Headquarters: Rio de Janeiro, Brazil
  • Date Invested: 07/24/2020
  • Visit Website

Doctor on Demand ×

Doctor on Demand is a virtual care platform that enables access to board-certified physicians for various medical and mental health conditions through employer, payor, and direct-to-consumer channels.

  • Region: United States
  • Sector: Healthcare
  • Headquarters: San Francisco, CA
  • Date Invested: 07/20/2020
  • Visit Website

Chi-Med ×

Hutchison China MediTech is an integrated biopharmaceutical company in China focused on innovative oncology therapies.

  • Region: China
  • Sector: Life Sciences
  • Headquarters: Hong Kong, China
  • Date Invested: 07/2/2020
  • Visit Website

Royalty Pharma ×

Royalty Pharma is an innovative biopharma company with a leading portfolio of commercial and pre-commercial drug royalties.

  • Region: United States
  • Sector: Life Sciences
  • Headquarters: New York, NY
  • Date Invested: 02/4/2020
  • Visit Website

CANbridge ×

CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China.

  • Region: China
  • Sector: Life Sciences
  • Headquarters: Beijing, China
  • Date Invested: 03/10/2020
  • Visit Website

Immunocore ×

Immunocore is a biotechnology company focused on therapies for oncology, viral diseases, and autoimmune disorders.

  • Region: EMEA
  • Sector: Life Sciences
  • Headquarters: Oxfordshire, United Kingdom
  • Date Invested: 08/13/2019
  • Visit Website

ACES ×

Comprehensive Educational Services (ACES) is a leading provider of applied behavioral analysis and ancillary services to individuals and families impacted with autism or other special needs.

  • Region: United States
  • Sector: Healthcare
  • Headquarters: Irvine, CA
  • Date Invested: 02/14/2020
  • Visit Website

Adagene ×

Adagene is a clinical-stage biotechnology company focused on developing innovative antibodies with superior safety and efficacy profiles.

  • Region: China
  • Sector: Life Sciences
  • Headquarters: Suzhou, China
  • Date Invested: 12/19/2019
  • Visit Website

Marathon Health ×

Marathon Health is a provider of primary care and population health management solutions for U.S. employers.

  • Region: United States
  • Sector: Healthcare
  • Headquarters: Winooski, VT
  • Date Invested: 10/7/2019
  • Visit Website

OcuMension ×

Ocumension is a clinical-stage biotechnology platform company focused on developing and commercializing innovative ophthalmology therapeutics in China.

  • Region: China
  • Sector: Life Sciences
  • Headquarters: Shanghai, China
  • Date Invested: 06/18/2019

Healthcare Sector Team VIEW ALL

Justin Sunshine

Managing Director New York

Justin Sunshine ×

Justin Sunshine is a Managing Director at General Atlantic and focuses on the firms Healthcare sector. Before joining General Atlantic in 2019, Justin was a Managing Director at The Blackstone Group where he focused on investments across the healthcare industry and worked in both the New York and London offices. He began his career at Accenture as a Consultant in the firms Strategy Practice.

Full Profile

Robbert Vorhoff

Managing Director,
Global Head of Healthcare
New York

Robbert Vorhoff ×

Robbert Vorhoff is a Managing Director and Global Head of General Atlantic’s Healthcare sector. He also serves on the firm’s Management Committee. Before joining the firm in 2003, Robb worked at Greenhill & Co., first in the mergers and acquisitions and restructuring advisory group, then in the private equity group, Greenhill Capital Partners.

Full Profile

Martín Escobari

Co-President,
Managing Director,
Head of Latin America
New York, São Paulo

Martín Escobari ×

Martín Escobari is Co-President, Managing Director and Head of General Atlantic’s business in Latin America. Martín is Chairman of the firm’s Investment Committee and also serves on the Management and Portfolio Committees.

Before joining General Atlantic in 2012, Martín was a Managing Director at Advent International where he focused on the financial services sector. Prior to that, he was Co-Founder and CFO of Submarino.com, a leading Brazilian online retailer that went public on the Bovespa and was sold to Lojas Americanas in 2006. Martin started his career as a management consultant at The Boston Consulting Group.

Full Profile

Sandeep Naik

Managing Director,
Head of India & Southeast Asia
Mumbai

Sandeep Naik ×

Sandeep Naik is a Managing Director and Head of General Atlantic’s business in India & Southeast Asia. He is also a member of the firm’s Management and Portfolio Committees. Before joining General Atlantic in 2012, Sandeep served as a Partner and Co-Head of India for Apax, leading investments in the healthcare, financial and business services, and retail and consumer sectors. Earlier in his career, he was Global Marketing Manager at Medtronic Inc., a scientist at Mayo Clinic, and a management consultant with McKinsey & Company. He is also the Co-Founder of InfraScan Inc., a medical device business focused on detecting bleeding inside the brain using a handheld device. Sandeep was selected as a Young Global Leader by the World Economic Forum and has served on the Global Agenda Council of New Order of Economic Thinking.

Full Profile

Joern Nikolay

Managing Director,
Head of Munich
Munich

Joern Nikolay ×

Joern Nikolay is a Managing Director and leads General Atlantic’s business in Germany, Austria, and Switzerland as part of the EMEA team. Prior to joining General Atlantic in 2008, Joern was an Associate at TA Associates in London. Before that, he was a Case Team Leader at Bain & Company in Düsseldorf, and an Analyst at Morgan Stanley in Frankfurt.

Full Profile

Rob Perez

Operating Partner New York

Rob Perez ×

Rob Perez is an Operating Partner and part of General Atlantic’s Operations Group, providing strategic support and advice to the firm’s investment team and portfolio companies in the Life Sciences sector. Before joining General Atlantic in 2019, he was Managing Director of Vineyard Sound Advisors, LLC, an advisory practice focused on growth companies in the biopharma industry. Prior to that, Rob was President and CEO of Cubist Pharmaceuticals, Inc. before its sale to Merck in 2015. Before joining Cubist in 2003, he served as Vice President of Biogen, Inc.’s CNS Business Unit.

Full Profile

Shantanu Rastogi

Managing Director Mumbai

Shantanu Rastogi ×

Shantanu Rastogi is a Managing Director and focuses on investments in the firm’s Financial Services, Healthcare, and Consumer sectors in the India & Asia-Pacific region. He rejoined General Atlantic in 2013 after working at the firm from 2005 to 2007. Previously, Shantanu was a Principal at Apax Partners, and prior to that, he was a Management Consultant at McKinsey & Company.

Full Profile

Eric Zhang

Managing Director,
Head of China
Beijing, Hong Kong, Shanghai

Eric Zhang ×

Eric Zhang is a Managing Director and Head of General Atlantic’s business in China.  Before joining the firm in 2016, Eric was a Global Partner and Managing Director at The Carlyle Group from 2006 to 2016 where he focused on investments in Asia. Previously, he was Vice President of Mergers and Acquisitions at Credit Suisse in Hong Kong, and prior to that, he was a Vice President in the Investment Banking division at China International Capital Corporation Limited in Beijing.

Full Profile

Rodrigo Catunda

Principal São Paulo

Rodrigo Catunda ×

Rodrigo Catunda is a Principal at General Atlantic and focuses on the firm’s investments across various sectors in Latin America. Prior to joining General Atlantic in 2011, Rodrigo was an Investment Banking Associate at J.P. Morgan in São Paulo and New York, focused on Latin America.

Full Profile

Luis Cervantes

Principal,
Head of Mexico Office
Mexico City

Luis Cervantes ×

Luis Cervantes is a Principal and leads General Atlantic’s Mexico City office, focusing on the firm’s growth investments in Mexico and across Latin America. Prior to joining General Atlantic in 2013, Luis was an Associate at Advent International where he concentrated on investments across sectors in Latin America. Previously, he was an Investment Banking Analyst at UBS in the Latin American group based in Mexico City. Luis also serves as an Adjunct Professor at Universidad Iberoamericana.

Full Profile

Christian Figge

Principal Munich

Christian Figge ×

Christian Figge is a Principal at General Atlantic and focuses on investments in Germany, Austria, and Switzerland. Prior to joining General Atlantic in 2012, Christian was a Research Assistant at the Technical University of Munich with a focus on empirical entrepreneurial finance topics. Before that, he worked at BC Partners and L.E.K. Consulting where he concentrated on the business services, healthcare, and industrial sectors.

Full Profile

Lefei Sun

Managing Director,
Head of Healthcare for China
Hong Kong

Lefei Sun ×

Lefei Sun is a Managing Director and Head of Healthcare for General Atlantic’s China region. Before joining the firm in 2018, Lefei was the Founding Partner of Huatai Healthcare Investment Fund. Prior to that, Lefei held various investment roles at Hony Capital, Credit Suisse, OrbiMed, Orchid Asia and a consultant role at McKinsey and Company, all in the healthcare sector.

Full Profile

Alexia Cesar

Vice President New York

Alexia Cesar ×

Alexia Cesar is a Vice President at General Atlantic and focuses on investments in the firm’s Healthcare sector. Prior to joining General Atlantic in 2019, Alexia oversaw the Medicaid Managed Care program at Massachusetts Executive Office of Health and Human Services. Prior to that Alexia was an Engagement Manager at McKinsey & Company in the Healthcare Practice, where she served clients in the government, pharmaceutical, payor and provider sectors.

Full Profile

Fletcher Gregory

Vice President New York

Fletcher Gregory ×

Fletcher Gregory is a Vice President at General Atlantic and focuses on investments in the Healthcare sector. Before joining General Atlantic, Fletcher was a Director at Bridge Growth Partners and an Associate at New Mountain Capital, where he covered investments in the healthcare, technology, financial services, and business services sectors. Fletcher began his career at Morgan Stanley in the Healthcare Group.

Full Profile

John LaDien

Vice President New York

John LaDien ×

John LaDien is a Vice President at General Atlantic and focuses on investments in the firm’s Healthcare sector. Prior to joining General Atlantic in 2014, John was an Analyst at Lazard in New York focusing on M&A.

Full Profile

Peter Lafer

Vice President New York

Peter Lafer ×

Peter Lafer is a Vice President at General Atlantic and focuses on investments in the firm’s Life Sciences sector. Before joining General Atlantic in 2018, Peter was a Principal at Essex Woodlands, a healthcare-focused growth equity firm. Peter began his career as an Investment Banking Analyst at J.P. Morgan in the Healthcare Group.

Full Profile

Jon Michael Reese

Vice President New York

Jon Michael Reese ×

Jon Michael Reese is a Vice President at General Atlantic and focuses on investments in the Healthcare sector. Prior to joining General Atlantic in 2017, Jon Michael worked for GTCR in Chicago as an Associate focusing on investments in the Healthcare sector. Jon Michael began his career as an Analyst in the Leveraged Finance Group at Bank of America Merrill Lynch.

Full Profile

Varun Talukdar

Vice President Mumbai

Varun Talukdar ×

Varun Talukdar is a Vice President at General Atlantic and focuses on the firm’s investments in the India & Asia-Pacific region. Before joining General Atlantic in 2013, Varun was an Investment Professional at Premji Invest where he concentrated on investments in the retail & consumer and education sectors. Prior to that, Varun worked with the Lehman Brothers Bankruptcy Estate in New York to manage and unwind its Indian private and public equity assets. He has also worked at Bayside Capital, the Miami-based credit investment arm of H.I.G. Capital, and in the Industrials Investment Banking division of Bank of America in New York.

Full Profile

Armaan Pai

Senior Associate New York

Armaan Pai ×

Armaan Pai is a Senior Associate at General Atlantic and focuses on investments in the Healthcare sector. Prior to joining General Atlantic in 2018, Armaan was an Analyst at Centerview Partners.

Full Profile

Vishal Parikh

Senior Associate New York

Vishal Parikh ×

Vishal Parikh is a Senior Associate at General Atlantic and focuses on investments in the firm’s Life Sciences sector. Before joining General Atlantic in 2018, Vishal was an Associate at Goldman Sachs in the Healthcare group. Prior to that, he worked as a Business Systems Analyst at Abbott Laboratories.

Full Profile

Walker Carpenter

Associate New York

Walker Carpenter ×

Walker Carpenter is an Associate at General Atlantic and focuses on investments in the firm’s Life Sciences sector. Before joining General Atlantic in 2017, Walker was a 2016 General Atlantic Summer Analyst.

Full Profile

Sophia DiPaolo

Associate New York

Sophia DiPaolo ×

Sophia DiPaolo is an Associate at General Atlantic and focuses on investments in the firm’s Life Sciences sector. Prior to joining General Atlantic in 2019, Sophia was an Investment Banking Analyst at Morgan Stanley, where she was part of the Healthcare Group.

Full Profile

Dr. Mohit Kaushal

Senior Advisor Palo Alto

Dr. Mohit Kaushal ×

Dr. Mohit Kaushal is a Senior Advisor at General Atlantic, providing strategic support and advice to the firm’s investment teams and portfolio companies in the Healthcare sector, drawing on his extensive career in investing, clinical medicine, academia, and public policy. Mohit served as a member of the White House Health IT task force during the Obama Administration and built and led the first dedicated healthcare team at the Federal Communications Commission. He serves on the Food and Drug Administration Safety and Innovation Act Workgroup of the Health IT Policy Committee and the National Committee on Vital and Health Statistics, advising Health and Human Services on data access and use. Mohit is also an ER physician, an Adjunct Professor of Biomedical Data Science at Stanford University, and continues to be active within public policy as a Scholar in Residence at the newly created Duke Margolis Center for Health Policy. Earlier in his career, he was a Visiting Scholar at the Brookings Institution.

Full Profile

Andy Slavitt

Senior Advisor New York

Andy Slavitt ×

Andy Slavitt is a Senior Advisor at General Atlantic, providing strategic support and advice to the firm’s investment teams and portfolio companies in the Healthcare sector. Before joining General Atlantic in 2017, Andy served as Acting Administrator for the Centers for Medicare & Medicaid Services (CMS) under President Obama. In this role, he spearheaded programs that provided access to quality healthcare for 140 million Americans, including Medicaid, Medicare, the Children’s Health Insurance Program (CHIP), and the Health Insurance Marketplace. Previously, Andy worked at UnitedHealth Group, serving as the Group Executive Vice President for Optum, a subsidiary of UnitedHealth Group, where he oversaw the delivery of clinical, technological, and operational solutions to healthcare clients and consumers from 2003 to 2013. Prior to this, he founded and served as CEO of HealthAllies, a venture backed technology-based consumer healthcare company, which he sold to UnitedHealth Group in 2003. Prior to HealthAllies, Andy was a consultant with McKinsey & Company and an investment banker with Goldman Sachs.

Full Profile

Dr. Glenn Steele, Jr.

Senior Advisor New York

Dr. Glenn Steele, Jr. ×

Dr. Glenn Steele, Jr. is a Senior Advisor at General Atlantic, providing strategic support and advice to the firm’s investment teams and portfolio companies in the Healthcare sector. Before joining General Atlantic in 2015, Glenn was President and Chief Executive Officer of Geisinger Health System. Previously, he served as the Richard T. Crane Professor in the Department of Surgery at University of Chicago, Vice President for Medical Affairs, and Dean of the Division of Biological Sciences at the Pritzker School of Medicine. Before that, Glenn was the William V. McDermott Professor of Surgery at Harvard Medical School, President and Chief Executive Officer of Deaconess Professional Practice Group, and Chairman of the Department of Surgery at New England Deaconess Hospital.

Full Profile

John Maraganore

Senior Advisor New York

John Maraganore ×

Dr. John Maraganore is a Senior Advisor at General Atlantic, providing strategic support and advice to the firm’s investment teams and portfolio companies in the Life Sciences sector. Since 2002, Dr. Maraganore has served as the CEO of Alnylam, a biopharmaceutical company focused on RNAi therapeutics. Prior to Alnylam, Dr. Maraganore served as an officer and a member of the management team for Millennium Pharmaceuticals, Inc. As Senior Vice President, Strategic Product Development for Millennium, he was responsible for the company’s product franchises in oncology, and cardiovascular, inflammatory, and metabolic diseases. He was previously Vice President, Strategic Planning and M&A and, prior to that, he was General Manager of Millennium BioTherapeutics, Inc., a former subsidiary of Millennium. Before Millennium, he served as Director of Molecular Biology and Director of Market and Business Development at Biogen, Inc. At Biogen, Dr. Maraganore invented and led the discovery and development of ANGIOMAX® (bivalirudin) for injection, formerly HIRULOGTM and currently marketed by The Medicines Company. Prior to Biogen, Dr. Maraganore was a scientist at ZymoGenetics, Inc., and the Upjohn Company.

Full Profile